Editorial Policy.

regeneration.center is built as an editorial health-information site, not as a volume-first publishing machine. The site exists to help readers understand regenerative medicine topics with enough structure, restraint, and review accountability that they can ask better questions and make better decisions about what to evaluate next.

That mission shapes what we publish and what we refuse to publish. We do not treat every search phrase as deserving its own URL. We do not copy a competitor’s sitemap because it happens to rank. We do not use blog posts as a dumping ground for evergreen medical queries that belong in a treatment, guide, or research page. Every page type on the site has a job, and editorial discipline starts by protecting those boundaries.

Editorial scope

The launch scope focuses on cautious regenerative medicine content for a North American audience. English and French are maintained together so bilingual routing, metadata, translation workflow, and publishing controls stay aligned from the start. Additional languages may follow after the source-language workflow remains stable under real publishing pressure.

We are building focused authority, not an encyclopedia. That means priority goes to condition clusters where commercial intent, educational need, and evidence interpretation meaningfully overlap. A topic can appear across multiple competitor sites and still remain outside our active publishing scope if it does not fit the site’s current strategy or review capacity.

How topics enter the system

Topics are selected from the master content map maintained outside the deployable site codebase. A proposed page does not move into drafting until the team answers a few practical questions.

1. Which page type owns the intent?
2. Does the topic fit the approved taxonomy and URL structure?
3. Does the page add distinct value, or would it repeat an existing treatment, guide, or research page?
4. Does the likely review burden match current editorial and medical-review capacity?

If a stronger page already covers the subject in the right amount of depth, we keep it there. A section does not become a standalone page just because a wording variant exists in keyword tools.

Page-type ownership rules

Treatment pages own commercial condition intent. Guide pages own educational modifiers such as condition overviews, stages, or what-to-expect framing. Research pages own evidence interpretation, mechanism summaries, and study-focused reading. Blog pages are reserved for updates, announcements, and time-sensitive editorial content.

That division matters because it prevents cannibalization and keeps readers on the clearest path. A guide should not quietly replace the treatment page that owns the main condition intent. A blog post should not become the accidental home for a durable medical query. Editorial planning is responsible for keeping those lines clear.

Drafting standards

Drafts are written for informed readers who need clarity, not hype. We use direct language, concrete explanation, and careful qualification. We avoid inflated certainty, broad promises, vague superlatives, and any sentence that implies a predictable clinical outcome from a public article.

Writers are expected to separate five things cleanly:

• what the condition is
• what questions matter during evaluation
• what published evidence suggests
• what remains uncertain
• what a public website can say responsibly before individualized review

That separation matters in every health field. It matters even more in regenerative medicine, where readers often arrive after seeing language that compresses research signals into sales claims.

Source handling and evidence framing

Editorial work is not finished when the page reads smoothly. The page also has to frame evidence honestly. That means writers and editors need to avoid flattening early data into mature consensus, avoid turning mechanistic discussion into implied efficacy, and avoid citing research in a way that hides study size, uncertainty, or mixed results.

The right editorial tone is often conservative. When a treatment area is still developing, the page should sound like that field is still developing. When evidence is mixed, the page should say so. When the site cannot responsibly answer a reader’s individual question without records or physician review, the page should stop at that boundary.

AI-assisted drafting and publishing controls

AI tools may support topic briefs, structural drafting, translation assistance, and internal QA. They do not have autonomous publishing authority for medically sensitive content. They are support tools inside a controlled workflow, not substitute editors.

Treatment pages, research pages, medically sensitive guides, oncology topics, and comparison pages that touch medications, prognosis, or therapeutic claims all stop for editorial revision and medical review before publication. Automation helps the team scale consistency. It does not bypass human judgment.

Translation and parity

English is the editorial source language. French mirrors the launched English structure so routing, metadata, and collection logic remain fully exercised. Translation is expected to preserve the meaning, caution level, and public medical boundary of the source copy. It is not acceptable for translated pages to drift into stronger claims or thinner explanations just because they are secondary-language assets.

If a translated page falls behind the source page materially, the editorial workflow should mark it for update rather than let it decay quietly.

Attribution, updates, and consolidation

Every page needs a clear owner inside the publishing workflow. Medically sensitive pages also need visible review metadata so readers can see when the page was reviewed and what level of review it passed through.

Updates may be triggered by new evidence, internal QA findings, taxonomy changes, translation drift, or the refresh interval assigned during publication. Some changes should lead to revision. Some should lead to consolidation. Some should lead to retirement. We do not preserve weak pages just because they already exist.

Independence and limitations

The site sits inside a real regenerative medicine business context, but that does not reduce the need for conservative language. Publication on this site does not mean a therapy suits every reader, that the evidence is complete for every claim, or that a public page can predict individual results.

The public website cannot replace individualized medical advice. Its job is to prepare a reader for a better next conversation, not to close the decision for them.

Corrections and continuous improvement

When the team identifies material inaccuracies, outdated passages, ambiguous claims, or structural cannibalization, the fix should move through the editorial workflow rather than through casual patching. Each page belongs to a larger content system. We want that system to stay coherent as it grows, which means pages need revision history, ownership, and the discipline to be merged or removed when they stop doing their job well.

If you want to see how that editorial system becomes visible on public pages, continue to the Reviewer Directory and the Medical Review Policy. If you want to see how this governance layer connects to the public inquiry and apply routes, read How Intake Works.